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Introduction
Controlled substances have been described as a drug or other substance strictly regulated by the
government due to the risk of abuse or addiction. This regulation covers how the substance is
manufactured, used, handled, stored, and disseminated. Opioids, stimulants, depressants,
hallucinogens, and anabolic steroids have been identified as controlled substances (Aro, Hussain,
& Bobrin, 2021). In 2019, overdoses involving opioids killed approximately 50,000 people in the
U.S., with synthetic opioids accounting for 73%of those deaths. Synthetic opioids, illicitly made
fentanyl, are at the heart of the overdose pandemic. Overdoses involving psychostimulants like
methamphetamine are also on the rise, both with and without the use of synthetic opioids (Scholl
et al., 2018). Even though controlled substances account for only 11% of all prescriptions written,
they were prescribed by 90% of clinicians, making it critical to include them in e-prescribing
systems (Thomas et al., 2012). The fact that different people have varying tolerance levels and
require different opioid doses to achieve adequate pain relief was a challenging aspect of caring
for patients with pain (D'Aunno et al. 2019)
With the implementation of Electronic Medical Record (EMR) systems, computerized order entry
systems have increased for medication prescriptions, which is now more common than handwritten
prescriptions. EMR can auto-populate a default number of pills prescribed, and one potential
method to alter prescriber behavior is to change the default number presented via the EMR system.
In addition, electronic prescribing for controlled substances has become more widely used as
providers and governments combat the opioid epidemic [Chiu et al., 2018).
A Prescription Drug Monitoring Program (PDMP) is an electronic database that tracks controlled
substance prescriptions in a state. PDMPs can provide health authorities timely information about
prescribing and patient behaviors that contribute to the epidemic and facilitate an agile and directed
response. Electronic Prescribing for Controlled Substances (EPCS) aimed to eliminate paper
prescriptions by allowing clinical prescribers to write prescriptions electronically, making them
digital and trackable for both the prescriber and the pharmacist and has been an essential part of
any health information technology system, as well as a requirement for 'meaningful use'
(Blumenthal & Tavenner, 2010). However, one of the single most difficult challenges for any
prescriber was distinguishing between the legitimate prescription of controlled substances and the
prescription potentially used for illegitimate purposes (Preuss et al., 2021).
To limit the likelihood of drug diversion and abuse, the DEA acknowledged the importance of
ensuring that the rules regulating electronic prescriptions did not unintentionally enable diversion
and abuse (Abramson et al., 2012). As a result, the DEA's Interim Final Rule on EPCS went into
effect in June 2010, allowing for e-prescribing and laying out the rules for its use in the U.S. (DEA,
2010). Providers, pharmacies, prescription system application vendors, and pharmacy system
vendors were all subject to the rules (Kannry, 2011).
EPCS aimed to reduce prescription opioid addiction, abuse, diversion, and death (Danovich et al.,
2019). Additionally, e-prescribing could improve healthcare quality, safety, and efficiency
(Kaushal et al., 2010). EPCS has enhanced patient management and reduced prescription fraud
associated with paper prescriptions, which account for a small but significant proportion of opioid
medications diverted for abuse (Fischer et al., 2010). EPCS gained popularity because of its ability
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to detect and prevent opioid diversion by removing paper prescriptions and allowing crossreferencing PDMP databases (Gawande, 2017). Without sacrificing convenience, EPCS provided
accountability and security and is a potent weapon in the fight against the nation's opioid problem
(Kausha et al., 2010).
While EPCS regulations could improve patient care and provide practitioners with more data for
quality improvement, they might also offer new obstacles to practitioners, facilities, and vendors
(Kaldy, 2016).
EPCS mandates were in place in 23 states by September 2021, and by 2022, all controlled drugs
covered by Medicare Part D must be dispensed through electronic prescribing (Imprivata., 2021).
In addition, many current state and local laws aimed at better tracking controlled-substance
prescriptions using e-prescribing technology, in conjunction with prescription drug monitoring
programs, have aided adoption (Everson et al., 2020).
This study's research purpose was to analyze and assess the association between electronic
prescribing-controlled substances and their impact on opioid prescribing.
Methodology
The working hypothesis was that electronic prescribing of controlled substances using the
Electronic Medical Record has led to reductions in opioid prescribing.
The conceptual framework for this research followed the research framework and process utilized
the adoption of technology by Yao et al. (2010). The methodology used for this research study was
a review of academic literature, involving the following steps:
Step 1: Literature Identification and Collection
The electronic databases of Marshall University nursing allied health, Marshall University Digital
Scholar, ProQuest, PubMed research databases, Evidence-Based Medicine, JAMA, and Cochrane
were searched for the terms "Electronic Prescription Controlled substances" OR "EPCS" OR "E
narcotics prescription" OR "Prescription AND "Pharmacology opioid misused" OR "OPIOIDS"
OR "DRUG Abuse" "AND "The United States." Using the Preferred Reporting Items for
Systematic Reviews and Meta-Analysis and PRISMA method (Moher et al., & The PRISMA
Group 2009), the search identified 28 relevant articles.
Step 2: Formation of Inclusion Principles and Literature Analysis
A total of 28 Articles, written in English and published from 2010-2022, with relevant information
about the electronic prescribing of controlled substances that intended to reduce opioid prescribing
rates by reducing fraud and experienced more significant reductions in opioid prescribing, were
scrutinized and used in the presentation of the project study.
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Results
In a study done in the United States between January 2014 and March 2015, the number of
pharmacies that were equipped with EPCS increased slightly, from 78% (46,711) to 79% (47,971)
across the country (Gabriel et al., 2016). The degree to which a state could help its citizens varied
tremendously. In March 2015, for example, state pharmacy enablement ranged from 30% to 92%.
The highest rate of EPCS pharmacy facilitation was in Rhode Island (96%), and the lowest was in
North Dakota (30%). Between January 2014 and March 2015, national EPCS enablement among
prescribers increased by 3.7%, with more enablement in the urban areas than rural areas (Gabriel
et al., 2016) (see Table 1).
Author(s)
Gabriel et al., 2016

Study
Secondary analysis of
electronic transactions
of controlled substances
from U.S. pharmacies
using Surescripts

Cao, Monteiro,
Wills, 2020

& Cross sectional survey
of 92 medical directors
in ACS-verified and
state designated level 1
and level 2 pediatric
trauma centers
Kivekäs, et al., 2016
Web-based survey done
in Finland involving
269
general
practitioners (GPs)
Achar, Sinha, & Systematic review of 7
Norcross, 2021
studies
published
between 1990-2020

Meisenberg
2018

et

al., Evaluation of morphine
milligram equivalents
(MME), 44,000 clinical
encounters pre and post
multifocal
education
intervention from June
2015-April 2018 in a
single setting healthcare
facility

Outcome
The highest rate of EPCS pharmacy facilitation was
in Rhode Island (96%) and the lowest was in North
Dakota (30%).
From January 2014-March 2015 the number of
pharmacies that were equipped with EPCS increased
slightly from 78% (46,711) to 79% (47,791)
Physician residents were the most common provider
who supplied opioid prescriptions at discharge
(79.1%), advanced practice professionals (APP,
77.6%), and attending physicians (71.6%)

GPs' job flexibility has been boosted by electronic
health records and e-prescribing

Benefits of EPCS with EHR included fewer
prescribing errors (from 12% to 0%), a decrease of
53% opioid prescriptions in New York after the
EPCS mandate, and savings ranging from $1.4
million to $1.1 billion
Post intervention the monthly MME per encounter
was 58% lower than the average of the 6-month
baseline, MME per opioid prescription per month
was 34% less than the average of the baseline and
the opioid prescription rate was 38% lower than the
average
of
the
baseline
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Chiu et al., 2018

Pre/post study of 1447
pre intervention, 1463
post
intervention
procedures, with the
intervention being the
lowering the default
opioid
prescription
from 30 to 12 pills
prescribed
after
procedures
Single site dental urgent
care in New York, pre
post intervention (1,464
subjects), with the
intervention being a
mandatory prescription
drug
monitoring
program

After the default change, the median number of
opioid pills prescribed decreased from 30
(interquartile range, 15-30) to 20 (interquartile
range, 12-30) per prescription. The percentage of
prescriptions written for 30 pills decreased from
39.7% before the default change to 12.9% after the
default change and the percentage of prescriptions
written for 12 pills increased from 2.1% before the
default change to 24.6% (after the default change).

Brandeau, Pitt, & U.S. population aged 12
Humphreys, 2018
years and older, using
11
different
intervention strategies
García et al., 2019
EHR
retrospective
prescription data from
31,422 primary care
providers
serving
approximately
17
million patients over
166
weeks
using
Athenahealth EHR

National policy, including electronic prescribing and
prescription drug monitoring le d to a decrease in the
illegal opioid prescription supply

Rasubala et al., 2015

For patients who were prescribed pain medications,
452 (30.6%), 190 (14.1%), and 140 (9.6%) received
opioid analgesics in the three study periods
respectively, signifying a statistically significant
reduction in the number of opioid prescriptions after
implementation of the mandatory PDMP (p<0.05).
Total numbers of prescribed opioid pills in a 3month period decreased from 5096 to 1120,
signifying a 78% reduction in absolute quantity.
Dowell, Haegerich, & Meta-analysis
States implementing mandatory PDMP and pain
Chou, 2016
performed by CDC on clinic laws reduced the combined drug overdose
US patients
death rate by−1.1 per 100,000 residents

Overall percentage ranged from 5.2% in large
central metropolitan counties to 9.6% in noncore
counties.
Patients in noncore counties had an 87% higher
chance of receiving an opioid prescription than did
patients in large central metropolitan areas during
the study period.
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Chua et al., 2022

Single-center
Rates of opioid prescribing were similar
retrospective study of preintervention and postintervention (61% vs
1107 children with 56%, P = 0.13). After the change to the default
forearm and elbow quantity, the median number of doses decreased
fractures who presented from 18 to 12 doses, with opioid prescriptions of 30
to
the
emergency or more doses dropping from 35% to 11%.
department
for
evaluation
and
subsequent orthopedic
follow-up
between
January
15,
and
September 19, 2017.
The default dispensing
quantity was decreased
on June 1, 2016 from 30
doses to 12 doses.
Table 1. Summary Of Studies by Study Design and Outcomes

Physician residents were the most common kind of provider who supplied opioid prescriptions at
discharge (79.1%), followed by advanced practice professionals (APP, 77.6%), and finally
attending physicians (71.6%) (Cao et al., 2020). However, according to a web-based survey done
in Finland involving 269 general practitioners (GPs), G.P.s' job flexibility has been boosted by
electronic health records and e-prescribing (Kivekäs et al., 2016).
Electronic prescription of controlled substances and fraud
EPCS improved patient safety by reducing the risk of fraud and diversion observed with paper
opioid prescriptions. With up to 9% of opioid paper prescriptions suspected of being forged or
fraudulent, the widespread use of EPCS has influenced opioid prescribing (Achar, Sinha, &
Norcross, 2021). According to the DEA, EPCS reduced the following types of prescription
diversion: stealing prescription pads or printing them and writing non-legitimate paper
prescriptions; altering a legitimate prescription to obtain a higher dose or more dosage units (e.g.,
changing a "10" to a "40"); phoning-in non-legitimate remedies late in the day when it is difficult
for a pharmacy to complete a confirmation call to the practitioner's office; and altering a
prescription record at the pharmacy to hide diversion from pharmacy stock (Achar et al., 2021).
Electronic prescribing of controlled substances and the opioid crisis
In a case study done at Anne Arundel Medical Center from April 2016 to April 2018, about 44,000
clinical contacts were documented. From a beginning level of 34.4 morphine milligram
equivalents (MME) per month, the total health system MME per encounter decreased by 1.0 MME
per month. The monthly MME per interaction was 58% lower after the post-intervention
observation than the 6-month baseline average. From a baseline level of 428 MME per month,
morphine milligram equivalents per opioid prescription declined by 8 MME per month. The MME
per prescription each month was 34% lower after the 16-month post-intervention period than at
the start (Meisenberg, Grover, Campbell, & Korpon, 2018). From a starting point of 11.5%, the
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percentage of clinical contacts resulting in an opioid prescription was lowered by 0.2% each
month. As a result, the opioid prescription rate was 38% lower at the end of the 16-month postintervention period than at the start (Meisenberg et al., 2018).
A case study done at Yale-New Haven Health System from February 2017 to August 2017
revealed that the median number of opioid pills prescribed per surgery reduced from about 30 pills
before the prescription default modification to about 20 pills following the change in the
prescription default (Chiu et al., 2018). Prescriptions issued for 30 pills reduced from 39.7% (554
of 1397) before the EPCS to 12.9% (183 of 1420) after the EPCS, while prescriptions written for
12 pills rose from 2.1% (29 of 1397) before EPCS to 24.6% (349 of 1420) after EPCS. The number
of prescriptions written for 20 tablets increased significantly from 12.2% (171 of 1397) before
EPCS to 19.6% (278 of 1420) after EPCS. After acquiring EPCS, the total opioid prescription was
reduced by 34.41 MME (Chiu et al., 2018).
In a study done at a dental facility in New York from over three months before the required
Prescription Drug Monitoring Programs (PDMP), and from December 1, 2013, and February 28,
2014, after PDMP implementation, the most prescribed opioid analgesics were hydrocodone,
codeine, and oxycodone (Rasubala et al., 2015). Ibuprofen and acetaminophen were the most
prescribed non-opioid analgesics. Following the mandated PDMP's introduction, there was a
general trend toward fewer opioid prescriptions and more non-opioid analgesic prescriptions by
the end of the trial, the total number of opioid analgesics prescribed over three months dropped
from 5096 to 1120 pills, a 78% decrease in absolute numbers (Rasubala et al., 2015).
States implementing mandatory PDMP and pain clinic laws reduced the combined drug overdose
death rate by−1.1 per 100,000 residents (Dowell et al., 2016). In addition, combining mandatory
provider reviews of state-run prescription drug monitoring program data with pain clinic
regulations reduced opioid prescription volumes by 8% and prescription opioid overdose death
rates by 12% (Brandeau et al., 2018).
Concerns that lowering opioid prescribing rates may lead to more patients experiencing
unmanaged pain. Chua et al. (2022) found this is not a valid concern. These researchers evaluated
opioid prescriptions for 1107 patients in a single site emergency department and discovered that a
reduction in opioid prescriptions of 30 or more doses from 35% to 11% led to no significant change
in reported pain management for the patients (Chua et al., 2022).
Interestingly and most concerning to Appalachia, researchers have found that opioid prescribing
by primary care providers have been much higher in rural than in urban counties due to that
population abusing opioids at a younger age, and /or because rural areas tend to have a large elderly
population who have been coping with chronic pain (García et al. (2019).
Cost of implementation of electronic prescribing for controlled substances.
The cost of implementing an advanced system with alarms, reminders, and system integration was
$29,000 per physician the first year and $4,000 per physician each year after that (Hahn & Lovett,
2014).
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Discussion
EPCS has been an essential tool in healthcare facilities. It facilitated the monitoring of prescribed
controlled substances, curbing prescription errors and abuses that might occur. In addition, EPCS
provides a complete record of controlled substance prescription; both physicians and patients can
be monitored through it. These are particularly important for public health and law enforcement
initiatives like the DEA addressing misuse and diversion of opioid medications.
The clinical response to the opioid crisis demands an obligation from health systems and their
physician leaders. They employ or contract with many clinicians both in hospitals and in the
community, propose and carry out quality improvement, have a mission to improve and protect
the public's health, and existing channels of communication to educate and inform the public and
patients about opioid risks and alternatives.
The CDC issued the CDC Guideline for Prescribing Opioids for Chronic Pain in 2018 to supply
recommendations for prescribing opioid pain drugs for patients 18 and older in primary care
settings, and on February 10, 2022, it released a draft revision to its 2018 opioid prescribing
guideline. If observed by pharmacy chains, health insurance companies, and policymakers, this
new guideline supplies a way to withdraw unplanned prescribing thresholds, correct balance, and
sustain complete, compassionate treatment.
Physicians have been prescribing fewer opioid painkillers as the medical system deals with the
current opioid epidemic. The emphasis has been on primary care doctors treating chronic or acute
pain, but every patient who receives anesthesia receives fentanyl, an IV opioid more potent than
heroin. As a result, coming up with alternatives is problematic. Nothing treats pain like opioids,
but it is possible to use a mixture of pre-and post-surgery methods, like nerve blocks, drugs
equivalent to Novocain, and even Tylenol to get the desired effect. However, those alternatives
have been slow to catch on.
Practical Implication
Opioid-related instruction has been being acknowledged as an essential topic, but its adoption in
many medical schools has been limited by a lack of time available in medical education and
promising strategies for assessing students’ learning
The practical suggestion resulting from this literature and case study must be evaluated in the
future analysis, including consideration of outcome for the control of opioids epidemic nationwide
after implementing Electronic Prescription Controlled substances effect achieving scale. Adopting
EPCS widely might improve overall safety efficacy, quality, and control of the opioid crisis.
Further research using a meta-analysis design is advised to measure the effect size of EPCS.
These implications are enormous with the current opioid crisis in Appalachia, particularly in West
Virginia, Kentucky, and southern Ohio. Reducing the availability of opioid prescriptions and
tracking prescriptions may enable clinicians, social services, law enforcement, and substance
abuse treatment professionals to work together to decrease opioid abuse and addiction.
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Conclusion
This review has shown that the utilization of the EMR and electronic prescribing has had the
potential to detect and prevent opioid diversion by eliminating paper prescriptions and improving
healthcare quality, safety, and efficiency while also lowering drug costs. Therefore, providers who
have been prescribing controlled medications should use electronic prescribing that reduces or
prevent adverse effects from avoiding misuse.
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